Overall, these findings suggested that knockdown of AURKB downregulated MAD2L2 to upregulate the p53 pathway, cell cycle arrest and cellular senescence, resulting in the suppression of BC cell proliferation. This evidence concerns the gene MAD2L2 and breast cancer.